Kawamori D, Shirakawa J, Liew CW, Hu J, Morioka T, Duttaroy A, et al
One literature review published in JAMA in April 2025 by a group of Irish researchers stated that GLP-1 drugs are known to reduce inflammation, improve insulin signaling, and promote neurogenesis, all of which could protect against cognitive decline. These potential benefits could also have an effect on cancer outcomes
Researchers say the pill could offer a more accessible alternative to injectable weight-loss medications
Patients with a history of thyroid C-cell tumors or Multiple Endocrine Neoplasia syndrome type 2 (MEN2) should not use GLP-1 medications
The first wave of generic versions of Novo Nordisk's GLP-1 weight-loss drugs launched in India over the weekend, with at least five domestic drugmakers undercutting the original price by up to 80%